Return On Equity of Eiger BioPharmaceuticals, Inc. from 30 Sep 2014 to 31 Dec 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Eiger BioPharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2014 to 31 Dec 2023.
  • Eiger BioPharmaceuticals, Inc. Return On Equity for the quarter ending 31 Dec 2023 was -870%, a 650% decline year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Return On Equity for 2023 was -870%, a 650% decline from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Return On Equity for 2022 was -116%, a 240% decline from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Return On Equity for 2021 was -34%, a 62% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Eiger BioPharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2023 -870% -754% -650% 01 Oct 2023 31 Dec 2023
Q3 2023 -332% -226% -212% 01 Jul 2023 30 Sep 2023
Q2 2023 -208% -110% -113% 01 Apr 2023 30 Jun 2023
Q1 2023 -143% -49% -53% 01 Jan 2023 31 Mar 2023
Q4 2022 -116% -82% -240% 01 Oct 2022 31 Dec 2022
Q3 2022 -106% -77% -261% 01 Jul 2022 30 Sep 2022
Q2 2022 -98% -75% -324% 01 Apr 2022 30 Jun 2022
Q1 2022 -93% -71% -322% 01 Jan 2022 31 Mar 2022
Q4 2021 -34% +56% +62% 01 Oct 2021 31 Dec 2021
Q3 2021 -29% +71% +71% 01 Jul 2021 30 Sep 2021
Q2 2021 -23% +92% +80% 01 Apr 2021 30 Jun 2021
Q1 2021 -22% +83% +79% 01 Jan 2021 31 Mar 2021
Q4 2020 -90% +15% +15% 01 Oct 2020 31 Dec 2020
Q3 2020 -101% +0.19% +0.19% 01 Jul 2020 30 Sep 2020
Q2 2020 -115% -0.74% -0.65% 01 Apr 2020 30 Jun 2020
Q1 2020 -105% +16% +13% 01 Jan 2020 31 Mar 2020
Q4 2019 -105% +22% +17% 01 Oct 2019 31 Dec 2019
Q3 2019 -101% +55% +35% 01 Jul 2019 30 Sep 2019
Q2 2019 -114% +42% +27% 01 Apr 2019 30 Jun 2019
Q1 2019 -121% +106% +47% 01 Jan 2019 31 Mar 2019
Q4 2018 -127% +69% +35% 01 Oct 2018 31 Dec 2018
Q3 2018 -156% +14% +8% 01 Jul 2018 30 Sep 2018
Q2 2018 -157% -28% -22% 01 Apr 2018 30 Jun 2018
Q1 2018 -227% -111% -96% 01 Jan 2018 31 Mar 2018
Q4 2017 -196% -97% -98% 01 Oct 2017 31 Dec 2017
Q3 2017 -169% -103% -156% 01 Jul 2017 30 Sep 2017
Q2 2017 -129% -70% -119% 01 Apr 2017 30 Jun 2017
Q1 2017 -116% -46% -66% 01 Jan 2017 31 Mar 2017
Q4 2016 -99% -59% -145% 01 Oct 2016 31 Dec 2016
Q3 2016 -66% -58% -735% 01 Jul 2016 30 Sep 2016
Q2 2016 -59% -49% -474% 01 Apr 2016 30 Jun 2016
Q1 2016 -70% -80% -781% 01 Jan 2016 31 Mar 2016
Q4 2015 -40% -37% -1134% 01 Oct 2015 31 Dec 2015
Q3 2015 -7.9% +13% +62% 01 Jul 2015 30 Sep 2015
Q2 2015 -10% 01 Apr 2015 30 Jun 2015
Q1 2015 10% 01 Jan 2015 31 Mar 2015
Q4 2014 -3.3% 01 Oct 2014 31 Dec 2014
Q3 2014 -21% 01 Jul 2014 30 Sep 2014

Eiger BioPharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2023 -870% -754% -650% 01 Jan 2023 31 Dec 2023
2022 -116% -82% -240% 01 Jan 2022 31 Dec 2022
2021 -34% +56% +62% 01 Jan 2021 31 Dec 2021
2020 -90% +15% +15% 01 Jan 2020 31 Dec 2020
2019 -105% +22% +17% 01 Jan 2019 31 Dec 2019
2018 -127% +69% +35% 01 Jan 2018 31 Dec 2018
2017 -196% -97% -98% 01 Jan 2017 31 Dec 2017
2016 -99% -59% -145% 01 Jan 2016 31 Dec 2016
2015 -40% -37% -1134% 01 Jan 2015 31 Dec 2015
2014 -3.3% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.